Sightline Wealth Advisors’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Sightline Wealth Advisors’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$271K	Hold	1,715	–	–	0.1%	74
2026 Q1	$219K	Hold	1,715	–	–	0.09%	81
2025 Q4	$209K	Buy	+1,715	New	+$197K	0.09%	90

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

JFG

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

Sightline Wealth Advisors's XBI Position: Q2 2026 in Review

Sightline Wealth Advisors held its State Street SPDR S&P Biotech ETF (XBI) position steady in Q2 2026 at 1,715 shares worth $271K. The position accounts for 0.1% of the portfolio, ranked #74.

Sightline Wealth Advisors first reported a position in XBI in Q4 2025 and has held it in 3 quarters since. 936 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

Sightline Wealth Advisors held 1,715 shares of State Street SPDR S&P Biotech ETF worth $271K as of Q2 2026.
Sightline Wealth Advisors left its State Street SPDR S&P Biotech ETF share count unchanged in Q2 2026.
State Street SPDR S&P Biotech ETF made up 0.1% of Sightline Wealth Advisors's portfolio in Q2 2026, its #74 holding.
Sightline Wealth Advisors first reported a position in State Street SPDR S&P Biotech ETF in Q4 2025 and has held it in 3 quarters since.
936 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Sightline Wealth Advisors's 13F filing for Q2 2026, filed 22 Jul 2026.